New Jersey Licensed Outpatient Group Facility: Ketamine Therapy Announced

Nov 16, 2023

Summary

Relevance Behavioral Health, a renowned outpatient care facility in New Jersey, has announced its entrance into ketamine therapy. As a licensed provider of Spravato, a ketamine-derived medication, Relevance Behavioral Health aims to revolutionize mental health treatment. Spravato, which contains esketamine, has shown promise in providing relief for individuals suffering from treatment-resistant depression. Unlike traditional antidepressants, ketamine therapy offers rapid relief, making it an attractive option for those who have not found success with other medications. By increasing glutamate levels in the brain, the medication offers greater efficacy in relieving symptoms. Moreover, Spravato has the potential to "reset" the chemical balance of the brain and reverse stress-related changes caused by untreated mental health conditions. Relevance Behavioral Health recognizes that ketamine therapy goes beyond the medication itself and emphasizes a holistic approach to address the root causes of mental health struggles. The licensed therapists utilize Spravato treatments to create a safe space for patients to explore their mental health challenges and substance use behaviors. The facility is committed to providing personalized care and guidance to individuals for whom ketamine therapy is suitable. Their goal is to offer diverse treatment options that cater to the unique needs of their clients. For more information about Relevance Behavioral Health and their ketamine therapy services, visit their website.

Relevance Behavioral Health (866-245-1497), a leading substance abuse and mental health disorder facility in New Jersey, is now offering ketamine therapy.

Freehold Township, United States - November 16, 2023 /PressCable/

Relevance Behavioral Health has become well-established as a leader in outpatient care in New Jersey and they have long embraced innovative and holistic treatment modalities. Now, they are pleased to be moving into ketamine therapy and are now a licensed provider of Spravato, a brand-name medication derived from ketamine which they believe holds transformative potential in reshaping approaches to mental health challenges.

More information is available at https://relevancerecovery.com/

Spravato’s active ingredient is esketamine, and the team at Relevance has seen that it can bring new hope to sufferers of treatment-resistant depression. Following its recent approval by the FDA, the trained medical professionals at Relevance Behavioral Health are pleased to now be offering and administering this innovative nasal spray medication.

Unlike traditional antidepressants, ketamine therapy offers rapid relief, making it an attractive option for individuals who have not experienced success with other medications. Because the medication increases glutamate levels, which are the brain’s primary chemical messenger, it has been proven to offer far greater efficacy in relieving the symptoms of treatment-resistant depression.

Moreover, Spravato has shown promise in "resetting" the chemical balance of the brain and countering stress-related changes in the brain, like the shrinkage of the hippocampus, therefore potentially reversing long-term damage caused by untreated mental health conditions.

Beyond the power of Spravato itself, Relevance Behavioral Health knows that the actual esketamine dosage is only one part of the value of truly transformative ketamine therapy, and their team of licensed therapists use their new Spravato treatments to create a safe space to better get to the source of a patient’s mental health struggles—and any subsequent substance use behaviors—whether it is unresolved trauma or neurochemical imbalances.

Relevance uses Spravato as a way to address these root causes and they are confident that their treatment can provide almost instant changes to mood, outlook, and energy levels. Thus, in the long-term, facilitating a smoother recovery process.

As a licensed care facility, Relevance Behavioral Health is committed to the appropriate administration of Spravato and they emphasize the importance of personalized care, ensuring that individuals for whom ketamine therapy is suitable receive the necessary guidance and monitoring.

A spokesperson for the licensed outpatient group facility said, “At Relevance, our commitment to pioneering advanced treatment approaches is unwavering. Our New Jersey Spravato treatments stand as a testament to our dedication to providing diverse options that cater to our clients’ unique needs, addressing the root causes of their mental health challenges.”

For more information, visit https://relevancerecovery.com/

Contact Info:
Name: Ashley Regan
Email: Send Email
Organization: Relevance Behavioral Health
Address: 61 W Main Street, Freehold Township, NJ 07726, United States
Phone: +1-866-245-1497
Website: https://relevancerecovery.com/

Source: PressCable

Release ID: 89113480

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at [email protected]. Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

More News

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.